News Overview

The total contract value is of ₹625.08 crore, including GST, with an expected time of completion of 30 months.

The three-year contract will involve TCS maintaining both the hardware and software of the system while implementing updates to enhance operations.

  Shilpa Medicare is the first Indian company to gain approval for Phase III trials of Recombinant Human Albumin.

Its module order is likely to be supplied starting FY 2025-26 and comes out from its own exchange filing.

Patanjali Foods reported a net profit of ₹309 crore for Q2 FY25, showing a 21.4% year-on-year growth compared to ₹254.5 crore in Q2 FY24.

The move resonates with Exide's commitment towards sustainable energy solutions and its role in driving India's transition to electric mobility and renewable energy.

The IPO was oversubscribed 12.52 times on the second day of public subscription. Today is the third and last day of bidding on the issue.

The system replicates actual battlefield and operation conditions with artificially intelligent responses from the targets, providing an effective simulation.

The dominant owners of Adani Wilmar currently hold 86.8% of the company, which is significantly more than the 75% maximum allowed.

Kia India accounts for 50% of Kia Corporation's global CKD exports, which makes it a vital contributor to Kia's global operations.